Pillstats
Rx only · Tablet · Oral

Doxepin

Doxepin Hydrochloride

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCD04AX01
RxCUI (US)3638
US makers4 labelers
Packages28
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.564$1.13$1.69$2.26Dec 2025Apr 2026Jul 2026
$1.393
Latest avg · Jul 22, 2026
-29%
Since Dec 17, 2025
4
Active US suppliers
86%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.9K5.8K8.7K12K2025 Q12025 Q22025 Q32025 Q42026 Q1
10K
Rx · 2026 Q1
316K
Units dispensed
+6924%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Viona Pharmaceuticals Incunknown12SUPPLYING
Zydus Lifesciences Limitedunknown12SUPPLYING
Aurobindo Pharma Limitedunknown2SUPPLYING
Ajanta Pharma USA Inc.unknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.